Notice for eculizimab (Soliris) (Alexion Pharmaceuticals Australasia Pty Ltd)
Active ingredients
eculizimab (Soliris)
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Solution for intravenous infusion
Indication
Treatment of patients with Neuromyelitis Optica Spectrum Disorder (NMOSD) who are anti aquaporin 4 antibody positive
Therapeutic area
Neurology